Vaxer Pharma Limited

Vaxer Pharma Limited - pharma in Urban Estate, Haryana, India. FY 2026 financials and compliance.
CIN U74999HR2011PLC122348 Incorporated 30 August 2011 ROC Delhi HQ Urban Estate, Haryana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹157.11 Cr
▲ 23.00% YoY
EBITDA · FY 2025
*****
▲ 108.00% YoY
Net profit · FY 2025
*****
▲ 154.00% YoY
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5.48 Lakh
Issued & subscribed
Open charges
₹15 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
5
Latest available

About Vaxer Pharma Limited

Data last updated: 17 December 2025

Vaxer Pharma Limited is a public limited company based in Urban Estate, Haryana, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 30 August 2011, the company has been in operation for over 15 years.

Registered with ROC Delhi under CIN U74999DL2011PLC224400.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹5.48 Lakh. It is led by directors including Bodh Raj Sikri and Pochiraju Hanumath Subba Rao.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Second Floor Sco – 313 Sector – 29, Urban Estate, Haryana, India – 122001.

As per the financials filed for FY 2025, the company reported a revenue of ₹157.11 Cr, a growth of 23% compared to the previous year.

The company has a workforce of approximately 5 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹15 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Vaxer Pharma Limited
CIN U74999HR2011PLC122348
Registration Number 122348
Incorporation Date 30 August 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Bodh Raj Sikri Director Pochiraju Hanumath Subba Rao Director Anshul Sikri Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Second Floor Sco – 313 Sector – 29, Urban Estate, Haryana, India – 122001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Vaxer Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vaxer Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Vaxer Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Vaxer Pharma Limited

Vaxer Pharma Limited has one previous CIN (Corporate Identification Number): U74999DL2011PLC224400. The current CIN is U74999HR2011PLC122348, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U74999HR2011PLC122348 Current
U74999DL2011PLC224400 Previous

Business Activity of Vaxer Pharma Limited

Vaxer Pharma Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G2 Retail Trading *********

Board of Directors of Vaxer Pharma Limited

Vaxer Pharma Limited is currently managed by 5 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Bodh Raj Sikri
Also directs: Abs Mercantiles Private Limited, Aumento Pallinos Private Limited, Nxis Hospitality Llp and 2 more
Director 16 Jan 2014 12 Years 5 Months Current
Pochiraju Hanumath Subba Rao
Also directs: Berg Healthcare Llp, S B Organics Ltd, Abs Mercantiles Private Limited and 1 more
Director 30 Aug 2011 14 Years 10 Months Current
Anshul Sikri
Also directs: Berg Healthcare Llp, Anm Pharma Private Limited
Director 30 Aug 2011 14 Years 10 Months Current
Suman Malhotra
Also directs: S B Organics Ltd
Director 27 Mar 2021 5 Years 3 Months Current
Aastha Dewan
Also directs: S B Organics Ltd, White Matter Global Private Limited
Director 27 Mar 2021 5 Years 3 Months Current
View all directors

Financials of Vaxer Pharma Limited FY 2024 filings available

Vaxer Pharma Limited reported revenue of ₹157.11 Cr (up 23% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹157.11 Cr ▲ 23%
Profit
***** ▲ 154%
EBITDA
***** ▲ 108%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Vaxer Pharma Limited

Open charges
₹15 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Yes Bank Limited₹15.00 Cr
Latest charge details
DateLenderAmountStatus
28 Dec 2022 Yes Bank Limited ₹15 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Vaxer Pharma Limited

View historical data on people associated with Vaxer Pharma Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Vaxer Pharma Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Vaxer Pharma Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Vaxer Pharma Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Vaxer Pharma Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Vaxer Pharma Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Vaxer Pharma Limited

MSME Payment Delays by Vaxer Pharma Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Vaxer Pharma Limited

Subsidiaries & Group Companies of Vaxer Pharma Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vaxer Pharma Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Vaxer Pharma Limited

MCA Filings & Documents of Vaxer Pharma Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Vaxer Pharma Limited

Activity
30 Sep 2024
Vaxer Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Vaxer Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
28 Dec 2022
A charge with Yes Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100667833 was registered on 28 Dec 2022.
Directors
27 Mar 2021
Suman Malhotra was appointed as a Director on 27 Mar 2021 & has been associated with this company since 5 years 3 months.
Directors
27 Mar 2021
Aastha Dewan was appointed as a Director on 27 Mar 2021 & has been associated with this company since 5 years 3 months.
Directors
16 Jan 2014
Bodh Raj Sikri was appointed as a Director on 16 Jan 2014 & has been associated with this company since 12 years 5 months.

Frequently Asked Questions about Vaxer Pharma Limited

Vaxer Pharma Limited is an active public limited company in the pharma sector based in Urban Estate, Haryana, India. It was incorporated on 30 August 2011 (15+ years old) and is registered under CIN U74999HR2011PLC122348. The company has 5 employees.

Vaxer Pharma Limited reported revenue of ₹157.11 Cr for FY 2025 (up 23.00% YoY).

The current directors of Vaxer Pharma Limited are:

The primary industry of Vaxer Pharma Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Vaxer Pharma Limited can be reached at the registered office: Second Floor Sco – 313 Sector – 29, Urban Estate, Haryana, India – 122001.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹5.48 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available